myeloid dendritic cell differentiation,NOTCH2,BATF3,TRAF6,SPI1,BATF2,LTBR,DHRS2,PSEN1,BATF,TGFB1,RELB,TGFBR2,RBPJ,CAMK4,CSF2,IL4,IRF4,UBD,DCSTAMP,
positive regulation of endothelial cell apoptotic process,CD160,FASLG,AKR1C3,PDCD4,CD248,ANO6,RGCC,THBS1,CCL2,ITGA4,PLCG1,CD40,COL18A1,PRKCI,ECSCR,HLA-G,FOXO3,GPER1,CD40LG,
myotube differentiation involved in skeletal muscle regeneration,BCL9,MYOD1,KLF5,
skeletal muscle cell differentiation,BCL9,MEF2D,MYOG,BTG2,ATF3,WNT3A,EGR2,ANKRD1,ANKRD2,VAX1,MYOD1,BCL9L,ANKRD33,NR4A1,MYF6,MYF5,RB1,KLF5,FOS,ASB2,COPS2,SOX8,NUPR1,ZNF689,HLF,HMG20B,EEF2,SOX11,FOXN2,SMYD1,KLHL41,MYLK2,MAFF,EOMES,PHOX2B,SAP30,MEF2C,EGR1,LEMD2,MED20,CITED2,PAX5,GTF3C5,NOTCH1,EMD,HEYL,HIVEP3,DMRTA2,
regulation of megakaryocyte differentiation,H3C13,RBBP5,H3-3A,PRKCQ,KMT2A,H4-16,KMT2D,NFE2,THBS1,SIN3A,TNRC6A,SETD1A,CBFB,ZFPM1,GP1BA,ITGA2B,H3-3B,TNRC6C,PRMT1,DPY30,EIF6,MYL9,L3MBTL1,RUNX1,TNRC6B,EP300,KAT2B,PF4,MEF2C,LOX,H4C3,H3C4,H4C8,H4C11,H3C12,KMT2E,CNOT4,KMT2C,ASH2L,NR4A3,WDR5,GATA1,MOV10,RBM15,PRMT6,HDAC1,AGO4,AGO1,AGO3,
metanephros development,APH1A,ITGA8,FGF8,HOXC11,GDF11,BMP4,FBN1,CTSH,IRX3,FOXC2,NF1,GREB1L,BCL2,ID2,OSR1,SIX2,PAX8,BMP7,ROBO2,SPRY1,IRX2,IRX1,NIPBL,GDNF,FGF10,HOXA11,GLI3,SHH,NKX3-1,SOX17,EYA1,RDH10,OSR2,CITED1,ID3,WNT4,
positive regulation of endothelial cell proliferation,ECM1,ARNT,IL10,VASH2,PROX1,AKT3,NRP1,CXCL12,SIRT1,VEGFB,ACVRL1,NR4A1,ANG,PRKD1,BMP4,HIF1A,PGF,AKT1,CDH13,CYBA,TNFSF12,NF1,CCL11,STAT5A,ITGB3,PRKCA,RPTOR,LRG1,MYDGF,PRKD2,EMC10,ZNF580,DYSF,PDCL3,BMPR2,NRP2,SCG2,HTR2B,BMP2,PPP1R16B,PDGFB,CCR3,WNT5A,KDR,FGF2,HMGB2,VEGFC,PDCD6,SEMA5A,RICTOR,AGGF1,THBS4,FLT4,BMP6,VEGFA,ARG1,VIP,CCL26,CCL24,CAV2,WNT2,EGR3,TEK,TGFBR1,EGFL7,NRARP,VEGFD,PLXNB3,NRAS,F3,JUN,MTOR,
positive regulation of vascular endothelial growth factor receptor signaling pathway,ARNT,ITGA5,FGF9,HIF1A,PRKCB,MT3,VTN,ITGB3,PRKD2,IL1B,FGF10,FGF18,GRB10,
positive regulation of vascular endothelial growth factor production,ARNT,PTGS2,NODAL,C3AR1,HIF1A,RORA,ADORA2B,BRCA1,CCBE1,C3,CXCL17,C5AR1,CYP1B1,EIF2AK3,IL1A,IL1B,SULF2,ATF4,HPSE,ISL1,IL6ST,FLT4,IL6,GATA4,SULF1,C5,NOX1,
muscle contraction,TMOD4,TPM3,CACNA1S,TNNT2,TNNI1,LMOD1,ACTA1,ACTN2,TACR2,VCL,ACTA2,MYOF,SORBS1,ANKRD2,KCNIP2,TNNI2,TNNT3,ACTN3,CRYAB,SSPN,MYL6B,MYL6,MYBPC1,NOS1,PXN,PABPN1,MYH6,MYH7,LTB4R,CALM1,TMOD2,TMOD3,TPM1,HCN4,CACNA1H,MYH11,MYLPF,TRIM72,GNAO1,CHRNE,CHRNB1,MYH13,MYH8,MYH4,MYH1,MYH2,KCNJ12,GJC1,SGCA,SCN4A,GALR2,MYOM1,MYL12A,MYL12B,GAMT,TPM4,FXYD1,RYR1,HRC,MYBPC2,TNNT1,TNNI3,SLC8A1,DYSF,ACTG2,SCN7A,TTN,MYL1,DES,CHRND,CHRNG,SNTA1,MYL9,P2RX6,CAV3,OXTR,STAC,SLMAP,LMOD3,MYLK,ITGB5,MYL5,NDUFS6,ITGA1,CERT1,CKMT2,MYOT,GLRA1,DRD1,TRDN,UTRN,TBX20,MYL7,MYL10,LMOD2,CALD1,CLCN1,MYOM2,SORBS3,ASPH,SNTB1,TPM2,TLN1,TMOD1,SLC6A8,EMD,TAZ,MYOM3,TRIM63,UTS2,
regulation of hematopoietic stem cell differentiation,PSMD4,PSMB4,GATA3,LDB1,PSMD13,LMO1,PSMA1,LMO2,PSMC3,YAP1,KMT2A,PSMD9,METTL3,PSMB5,PSMB11,PSME1,PSME2,PSMA6,PSMC6,PSMA3,PSMC1,TCF12,PSMA4,SETD1A,CBFB,PSMB10,PSMD7,PSMB6,PSMD11,PSMD3,PSME3,PSMC5,PSMD12,PSMA8,TCF3,PSMD8,PSMC4,EIF2AK2,PSME4,PSMD14,PSMD1,PSMF1,ITCH,PSMA7,RUNX1,OSM,PSMD6,GATA2,PSMD2,PSMB8,PSMB9,MYB,PSMB1,PSMA2,CDK6,SEM1,PSMC2,PUS7,PRKDC,PSMD5,PSMB7,ABL1,GATA1,PSMD10,PSMA5,YTHDF2,PSMB2,TAL1,TP73,
positive regulation of smooth muscle cell migration,S100A11,NRP1,P2RY6,NOX4,IGF1,POSTN,SEMA6D,CRK,VTN,BCL2,HDAC4,SRC,PDGFB,ITGA2,PDGFRB,HAS2,MYC,CCN4,FOXO4,
astrocyte development,S100A8,VIM,MT3,GFAP,LAMB2,EIF2B5,DRD1,AGER,POU3F2,DLL1,CDK6,ROR2,TLR4,LAMC3,PLP1,TSPAN2,ROR1,
endothelial cell migration,S100A2,NRP1,PTEN,CALCA,LPXN,PXN,STARD13,GREM1,CDH13,TNFSF12,GIPC1,CYP1B1,DPP4,FAP,SCG2,ITGB2,RHOA,PLXND1,PIK3CA,S100P,NOS3,PAXIP1,LOXL2,ADGRA2,PTK2,PTP4A3,PRSS3,TGFBR1,ABL1,PRKX,PLEKHG5,
negative regulation of smooth muscle cell proliferation,NPR1,ILK,SF1,IFNG,ANG,NDRG2,NDRG4,PTGIR,IGFBP5,COMT,HMOX1,PPARG,IL12A,APOD,PPARGC1A,IL15,NPR3,IL12B,AIF1,PPARD,TNFAIP3,VIP,IGFBP3,NOS3,VIPR2,TRIB1,OGN,KLF4,MFN2,CTNNBIP1,
endothelial cell chemotaxis,RAB13,NRP1,CORO1B,NR4A1,HMGB1,VEGFA,EGR3,CCN3,PLEKHG5,
muscle filament sliding,TPM3,TNNT2,TNNI1,ACTA1,ACTN2,VIM,TNNI2,TNNT3,MYBPC3,ACTN3,MYL6B,MYL6,MYBPC1,MYL2,MYH6,MYH7,ACTC1,TPM1,MYH8,MYH4,MYH2,MYH3,TCAP,MYL4,TPM4,MYBPC2,TNNT1,TNNI3,NEB,TTN,MYL1,DES,TNNC2,MYL3,TNNC1,TPM2,TMOD1,DMD,
hematopoietic stem cell homeostasis,UBAP2L,ADAR,TCIRG1,NLE1,CCN3,
positive regulation of smooth muscle cell proliferation,IL6R,PTGS2,FGFR2,TRAF6,PDGFD,IL18,IRAK4,IGF1,ABCC4,BMP4,MNAT1,AKT1,THBS1,RBPMS2,MMP2,CX3CL1,SMPD3,CDH13,CYBA,SERPINF2,ALOX12,PHB,ELANE,NOTCH3,ID2,CALCRL,STAT1,HDAC4,TGM2,HMOX1,PDGFB,TGFBR2,MYD88,FOXP1,PPARGC1A,EREG,NPY5R,SKP2,ITGA2,HMGCR,IL13,HBEGF,PDGFRB,EDN1,TNF,AIF1,MYB,IL6,EGFR,NAMPT,AKR1B1,MYC,CCN4,NR4A3,NOX1,IRAK1,S1PR1,JUN,PTAFR,HES5,MTOR,
vascular endothelial growth factor production,IL6R,HIF1A,ADGRG1,IL1B,ADAMTS3,TNF,IL6,
positive regulation of glomerular mesangial cell proliferation,IL6R,PDGFD,SERPINB7,CFLAR,PDGFB,
smooth muscle contraction,CHRNB2,CHRM3,HTR7,TPCN2,BDKRB2,CHRNB4,MYH11,ROCK1,ROCK2,FKBP1B,HTR2B,NMUR1,SMTN,MYLK,EDNRA,PDE4D,ADRA1A,HTR1D,
endocardial cushion to mesenchymal transition involved in heart valve formation,EFNA1,HEY2,
regulation of blood vessel endothelial cell migration,EFNA1,PRCP,ACVRL1,NF1,SH3BP1,EPHA2,
negative regulation of thymocyte apoptotic process,EFNA1,RAG1,BMP4,HIF1A,JAK3,ADA,PTCRA,
negative regulation of microglial cell activation,SYT11,PTPRC,CX3CL1,NR1D1,GRN,LDLR,CST7,TAFA3,
negative regulation of cardiac muscle hypertrophy in response to stress,LMNA,ATP2B4,FOXO1,SMAD3,MLIP,ERRFI1,
ventricular cardiac muscle cell development,LMNA,CDK1,MYH10,BMP10,FHL2,CCNB1,NKX2-5,ATG5,HEY2,NKX2-6,
regulation of endothelial cell migration,SEMA4A,GLUL,RHOJ,PDPK1,EMP2,CEACAM1,BMPER,PTN,PTK2,
positive regulation of vascular smooth muscle cell proliferation,MEF2D,IL10,AGT,BMPR1A,P2RY6,PAK1,FOXJ2,MDM2,IGF1,FGF9,MMP2,ERN1,DNMT1,IGFBP5,MMP9,ADAMTS1,PDGFB,GNAI2,FGF2,HPGD,TERT,NQO2,EDN1,DDX39B,TNF,HTR1B,GJA1,MAP3K5,JAK2,NR4A3,GNAI3,JUN,LDLRAP1,MFN2,
muscle organ development,MEF2D,MYOG,CENPF,MKX,SIRT1,ANKRD2,LBX1,SOX6,MYOD1,CSRP3,ALX4,KMT5B,CRYAB,TAGLN,USP2,TEAD4,ITGA7,MYF6,MYF5,IGF1,SGCG,ZBTB42,CAPN3,TCF12,ZNF609,ITGA11,BTBD1,UNC45A,CHD2,MEF2A,CACNA1H,MRTFB,PRR14,CTF1,TRIM72,ZFHX3,MYH3,COPRS,UNC45B,SGCA,MEF2B,NPHS1,EID2B,EID2,TCF23,VAMP5,NEB,MSTN,SPEG,PAX3,COL6A3,TCF15,LAMA5,CHODL,PAXBP1,TBX1,XBP1,SMTN,MAPK12,CAV3,FLNB,MRAS,FXR1,MSX1,EVC,SGCB,CXCL10,FRG1,MEF2C,MEGF10,HBEGF,SGCD,RIPOR2,H1-5,COL19A1,BVES,CD164,LAMA2,UTRN,FOXK1,ETV1,TWIST1,SRI,SGCE,EGR3,NRG1,JPH1,ADGRB1,CAVIN4,FKTN,MYMK,DMD,FOXO4,ITGB1BP2,FHL1,SRPK3,EMD,ID3,FHL3,PAX7,
vascular endothelial growth factor receptor signaling pathway,SH2D2A,NCF2,MAPKAPK2,ABI1,NRP1,DOCK1,VEGFB,NCKAP1L,PXN,FLT1,PRKD1,PGF,HSP90AA1,BCAR1,FOXC2,CYBA,CRK,ITGB3,BAIAP2,ROCK1,SHC2,VAV1,PIK3R2,AXL,PRKD2,ROCK2,NCK2,NCKAP1,ITGAV,NRP2,SRC,ELMO2,NCF4,MAPK11,BRK1,RHOA,MAPKAPK3,NCK1,PIK3CB,PIK3CA,PAK2,KDR,VEGFC,PIK3R1,CYFIP2,FLT4,FOXC1,MAPK14,VEGFA,FYN,RAC1,ELMO1,NCF1,PTK2B,SULF1,PTK2,SHB,VAV2,VEGFD,CYBB,VAV3,WASF2,CDC42,
striated muscle contraction,ARHGEF11,NOS1,MYH6,MYH7,ARG2,ALDOA,GAA,DTNA,TNNI3,KLHL41,TTN,MYLK2,LMOD3,SMPX,CASQ2,
lymphocyte homeostasis,SPTA1,TNFRSF17,LAT,SPNS2,FOXN1,BCL2,SOS1,BCL2L11,SLC40A1,SKIL,
myeloid cell differentiation,IFI16,PRDX3,CDKN1C,TCIRG1,ZBTB16,TIRAP,CEBPE,PML,KAT8,CBFB,IRF8,HOXB7,CEBPA,RASGRP4,NCOA6,SNRK,THPO,TET2,CSF2,L3MBTL3,CLEC5A,KAT6A,PRKX,PIR,GATA1,TAL1,
oligodendrocyte development,KCNJ10,MYRF,GSTP1,CD9,ASCL1,EIF2B1,WASF3,EIF2B2,TGFB1,SOX11,ID2,EIF2B4,NKX2-2,OLIG1,SOX10,HDAC10,HDAC11,EIF2B5,PRDM8,TPPP,NSUN5,SHH,LYN,LPAR1,GSN,MED12,EIF2B3,HES5,
skeletal muscle tissue development,IGSF8,CASQ1,MYOG,HLX,ZBTB18,SVIL,MYOZ1,NEURL1,MYOD1,CSRP3,MYL6B,MYL6,MYF6,MYF5,DCN,METTL21C,CFL2,SIX1,SIX4,NR2F2,MYLPF,NF1,NPHS1,MYH14,VAMP5,CCNT2,METTL8,HOXD10,HOXD9,CFLAR,GPCPD1,RCAN1,EP300,MYL3,RHOA,FLNB,POPDC2,KCNAB1,MYOZ2,MEF2C,MAPK14,COL19A1,BVES,POPDC3,VGLL2,MEOX2,ELN,FOXP2,CAV1,CDK5,MSC,DMD,SRPK3,TAZ,PAX7,
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,ATP1A2,RYR2,GSTO1,CACNA1C,CALM1,PRKACA,TMEM38A,CALM3,HRC,FKBP1B,SLC8A1,CALM2,ANK2,CAMK2D,PLN,TMEM38B,DMD,CLIC2,CASQ2,GSTM2,
regulation of muscle contraction,ATP1A2,TNNT2,PPP1R12B,TNNI2,TNNT3,KCNA1,TPM1,SSTR2,HSPB6,TNNT1,TNNI3,MYL9,TNNC2,TNNC1,MYL5,ANXA6,ADRA1B,ADRA1A,
regulation of smooth muscle contraction,ATP1A2,PLCE1,ADRA2A,CHRNA3,CHRNB4,P2RX1,DAPK3,CNN1,TNNI3,ADRA2C,NMU,ADRB2,NMUR2,CAV1,CHRM2,KCNB2,
regulation of striated muscle contraction,ATP1A2,TNNI1,MYBPH,TNNT3,MYBPC3,MYL2,MYL3,SRI,
negative regulation of striated muscle contraction,ATP1A2,GRK2,
regulation of cardiac muscle cell contraction,ATP1A2,ADORA1,KCNJ2,SUMO1,SCN5A,ANK2,PDE4D,PLN,SRI,GATA4,STC1,ATP1A1,PDE4B,
cardiac muscle contraction,ATP1A2,ATP1B1,TNNT2,TNNI1,RYR2,TNNI2,TNNT3,KCNQ1,CSRP3,MYBPC3,VEGFB,GRK2,SCN4B,SCN2B,SCN3B,MYL2,MYH6,MYH7,ACTC1,TPM1,MAP2K3,TCAP,MYL4,MAP2K6,GAA,SCN1B,PPP1R13L,TNNT1,TNNI3,SLC8A1,CXCR4,TTN,MYL1,MYLK2,SCN5A,MYL3,TNNC1,PIK3CA,SMAD5,SGCD,NKX2-5,KCNH2,DMD,KCNE5,TAZ,CASQ2,MTOR,
membrane depolarization during cardiac muscle cell action potential,ATP1A2,SCN4B,SCN2B,SCN3B,CACNA1C,HCN4,KCNJ2,HCN2,SCN1B,SLC8A1,SCN5A,CACNA1D,
relaxation of cardiac muscle,ATP1A2,ATP1B1,RGS2,ATP2A2,P2RX4,KCNJ2,SLC8A1,CAMK2D,PDE5A,PLN,ATP1A1,GSTM2,
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,CASQ1,DMD,GSTM2,
response to muscle inactivity,CASQ1,PKM,
response to denervation involved in regulation of muscle adaptation,CASQ1,MYOG,ACTN3,SGCA,MTMR4,HDAC4,SCN5A,DAG1,UTRN,FBXO32,DMD,
myeloid cell homeostasis,NCSTN,ITPKB,NCKAP1L,BAX,BCL2L11,SOD1,BAK1,FANCC,FOXP3,
muscular septum morphogenesis,VANGL2,FZD2,HEY2,FZD1,TGFBR3,
lymphocyte activation,SLAMF1,LAX1,CD3E,CARD11,
myeloid dendritic cell activation involved in immune response,SLAMF1,PYCARD,DOCK2,
establishment of endothelial intestinal barrier,F11R,TJP1,PTPRS,ICAM1,MYD88,CLDN1,RAPGEF2,AFDN,TJP2,RAP2C,
positive regulation of establishment of endothelial barrier,F11R,CDH5,S1PR2,PROC,CLDN5,ADD1,
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,NOS1AP,RNF207,
regulation of ventricular cardiac muscle cell membrane repolarization,NOS1AP,KCNQ1,KCNE3,SCN4B,SCN1B,KCNE4,SNTA1,KCNE2,KCNE1,CAV3,SCN5A,WDR1,ANK2,CACNA2D1,AKAP9,KCNH2,KCNE5,ZMPSTE24,
regulation of cardiac muscle cell action potential,NOS1AP,CAMK2D,
negative regulation of cell growth involved in cardiac muscle cell development,RGS4,RGS2,PAK1,YY1,CTDP1,GSK3A,PPARA,CAV3,PI16,G6PD,
dorsal root ganglion development,RGS4,TUBB3,CTNNB1,UNC5C,POU4F2,
branching involved in ureteric bud morphogenesis,PBX1,PAX2,FGF8,ILK,DCHS1,WT1,WNT1,BMP4,SIX1,PGF,SALL1,WNT9B,SOX9,GREB1L,SMAD4,BCL2,PAX8,HOXD11,WNT6,BMP2,GZF1,LAMA5,CTNNB1,DLG1,PKD2,NPNT,FGF2,FAT4,ADAMTS16,GDNF,FOXD1,TCF21,HOXA11,GLI3,SHH,EYA1,MYC,PTCH1,CITED1,GPC3,WNT4,CTNNBIP1,
skeletal muscle contraction,RCSD1,TNNT2,TNNI1,CHUK,TNNI2,TNNT3,STAC3,ATP2A2,MYH7,CCDC78,CHRNB1,MYH8,MYH3,STAC2,TCAP,JSRP1,EEF2,MYH14,TNNT1,TNNI3,CHRNA1,CHRND,TNNC2,STAC,TNNC1,HOMER1,
lymphocyte chemotaxis,XCL2,XCL1,C10orf99,ADAM8,SAA1,CCL22,CX3CL1,CCL17,CKLF,CXCL16,CCL2,CCL7,CCL11,CCL8,CCL13,CCL1,CCL25,CCL20,CCL26,CCL24,CCL19,CCL21,
positive regulation of thymocyte migration,XCL1,CCR2,
regulation of cardiac muscle contraction by calcium ion signaling,ATP1B1,RYR2,ATP2A2,TNNI3,SLC8A1,HDAC4,ANK2,SLC9A1,
membrane repolarization during cardiac muscle cell action potential,ATP1B1,KCNIP2,KCNQ1,YWHAE,KCNJ2,KCNE1,KCNH2,KCNE5,ATP1A1,KCND3,
skeletal muscle hypertrophy,MYOC,
cardiac muscle cell differentiation,CACYBP,ITGB1,SOX6,NOX4,TBX5,TBX3,BMP4,AKAP13,MESP1,KDM6B,MYOCD,IFT20,GATA6,CALR,BMP2,SIK1,CBY1,MEF2C,NKX2-5,GATA4,NRG1,TSC1,ACADM,ARID1A,SLC9A1,
neuromuscular process controlling balance,TNR,PSAP,HMX3,NKX6-2,TPP1,PTPRQ,JPH4,HERC1,IGDCC3,ALDH1A3,RBFOX1,CLN3,AARS1,JPH3,ABR,PAFAH1B1,DLG4,NLGN2,MYH10,CNTNAP1,GRIN2C,GAA,RAC3,CACNA1A,SHANK1,NRXN1,GIGYF2,FOXS1,APP,BCR,RBFOX2,ADCY5,CLRN1,BLOC1S4,POU4F2,SLC1A3,HEXB,TIFAB,NEUROG1,POU4F3,GM2A,CLN8,NBN,NR4A3,ABL1,GPR88,CAMTA1,
metanephric glomerular visceral epithelial cell development,NPHS2,LAMB2,
smooth muscle cell migration,ARPC5,PLAU,ITGB3,AAMP,DDR1,PLAT,CCN3,
negative regulation of smooth muscle contraction,PTGS2,PRKG1,CALCA,CALCRL,ADRB2,
positive regulation of smooth muscle contraction,PTGS2,CHRM3,CTTN,MYOCD,SPHK1,TBXA2R,ADA,RHOA,PROK2,NMU,NPNT,NPY2R,ITGA2,F2R,EDN1,SRF,ADRA1A,PTAFR,EDN2,
negative regulation of cardiac muscle hypertrophy,RGS2,GLRX3,TNFRSF1A,P2RX4,SMAD4,BMP10,GATA5,CAV3,JARID2,MLIP,NOTCH1,TRIM63,TNFRSF1B,
positive regulation of cardiac muscle contraction,RGS2,KCNQ1,CHGA,UCN,SMTN,CCN2,ADRA1A,ACE2,NPPA,
relaxation of vascular smooth muscle,RGS2,ADORA1,PRKG1,KCNMA1,ADORA2B,SOD1,GUCY1A1,
negative regulation of myeloid cell differentiation,CDC73,ITPKB,CTR9,ZBTB16,NFKBIA,MEIS2,LEO1,WDR61,HOXB8,PAF1,ZFP36,MEIS1,GATA2,GPR171,DLL1,HOXA9,CDK6,PTK2B,HMGB3,RBM15,
photoreceptor cell outer segment organization,CRB1,CDHR1,ROM1,BBS4,IFT140,CNGB1,IFT20,PCARE,PRPH2,AHI1,RP1,TOPORS,MFSD2A,NPHP4,
eye photoreceptor cell development,CRB1,TH,PAX6,MYO7A,MFRP,CEP290,RPGRIP1,FSCN2,RDH13,GNAT1,PRKCI,TULP1,VEGFA,PRDM1,GNGT1,RORB,OLFM3,
photoreceptor cell maintenance,CRB1,USH2A,ERCC6,PCDH15,CDH23,CDHR1,TUB,USH1C,BBS1,MDM1,BBS10,RDH12,ESRRB,SPATA7,BBS4,CIB2,BBS2,CNGB1,ATP1B2,USH1G,NXNL1,MKKS,IQCB1,RHO,NPHP3,CLRN1,PROM1,BBS12,ADGRV1,MAK,TULP1,LCA5,USP45,CLN8,RP1L1,RP1,NXNL2,DRAM2,ABCA4,SLC2A1,CROCC,NPHP4,
DN2 thymocyte differentiation,PTPRC,CCR6,
positive regulation of hematopoietic stem cell migration,PTPRC,CCR2,
intestinal epithelial structure maintenance,INAVA,ZNF830,SOX9,IL17A,TLR4,
ventricular cardiac muscle tissue morphogenesis,TNNT2,TNNI1,PROX1,FGFR2,MYBPC3,PKP2,MYL2,MYH6,MYH7,TPM1,FOXC2,SMAD7,TGFB1,TNNI3,BMP10,FKBP1A,MYL3,TNNC1,ISL1,PTCD2,HAND1,FOXC1,RXRA,COL11A1,TGFBR3,
regulation of muscle filament sliding speed,TNNT2,TNNC1,
muscle tissue development,CSRP1,CSRP3,CSRP2,POGLUT1,SRPK3,
negative regulation of astrocyte differentiation,GPR37L1,F2,NTRK3,NF1,NOG,MYCN,ID4,NR2E1,DAB1,HES5,
lens fiber cell differentiation,KDM5B,SMAD3,NTRK3,MAF,FZR1,TGFB1,SIX3,CRYGD,NF2,SKIL,SLC7A11,TDRD7,
positive regulation of muscle atrophy,MYOG,FOXO3,
positive regulation of muscle cell differentiation,MYOG,MYOD1,RBM4,CDON,TARBP2,MDM2,MYF6,MYF5,SETD3,BNIP2,MEF2A,CDH15,SPAG9,CDH2,TCF3,CTNNA2,MAPK12,MAPK11,CAMK1,CTNNB1,BOC,MEF2C,CTNNA1,MAML1,MAPK14,ABL1,CDC42,
striated muscle atrophy,MYOG,GSN,
muscle cell fate commitment,MYOG,MYOD1,MYF6,MYF5,TBX1,FGF10,
positive regulation of skeletal muscle fiber development,MYOG,MYOD1,ACTN3,MYF6,MYF5,BCL2,LMOD3,SHOX2,NIBAN2,
skeletal muscle atrophy,MYOG,ACTN3,MSTN,CFLAR,PPARGC1A,IL15,TRIM63,
regulation of skeletal muscle satellite cell proliferation,MYOG,SIX1,CFLAR,PAXBP1,PPARD,ANGPT1,
response to muscle activity,MYOG,TOMM20,RYR2,TNS2,POSTN,HIF1A,ADSS1,CAPN3,GOT2,METRNL,ABCG5,ABCG8,MSTN,ATP5PF,MTFP1,ADSL,OPA1,PPARGC1A,SRD5A1,ITGA2,NPC1L1,FIS1,PRKAA2,FNDC5,PERM1,
response to muscle activity involved in regulation of muscle adaptation,MYOG,AGT,PRKAG3,
response to electrical stimulus involved in regulation of muscle adaptation,MYOG,PPARGC1A,TRIM63,
muscle cell differentiation,MYOG,H3-3A,SOX6,RORA,MYOCD,H3-3B,SEMA4C,BIN1,SPEG,HIRA,FBXO40,ASF1A,SYNE1,QKI,SMARCD3,DMD,GLMN,
skeletal muscle tissue regeneration,MYOG,WNT10B,TARBP2,NACA,MYF6,KLF5,PKM,ENO3,SOX15,SGCA,DYSF,MSTN,CFLAR,LARGE1,GPX1,DAG1,PPP3CA,EYS,MTPN,BIN3,MYMK,DMD,PAX7,
skeletal muscle fiber development,MYOG,ACTA1,MYOD1,WNT10B,STAC3,P2RX2,SIX1,RYR1,KLHL41,DNER,RCAN1,KLHL40,GPX1,LMOD3,PPP3CA,HOMER1,RIPOR2,CAV2,SMO,KEL,BIN3,MYORG,XK,SELENON,SKI,
regulation of cardiac muscle contraction,ADORA1,RYR2,NOS1,P2RX4,CALM1,HCN4,SMAD7,PRKACA,CALM3,EHD3,CALM2,ASB3,BMP10,CAV3,SCN10A,ANK2,ADRA1B,NKX2-5,ADRA1A,TNNI3K,RNF207,
negative regulation of blood vessel endothelial cell migration,ATP2B4,ACVRL1,HMGB1,RGCC,VASH1,THBS1,DLL4,JUP,APOE,ANGPT4,PPARG,HRG,FGF2,MEF2C,TNF,CSNK2B,ANGPT2,AGTR2,MECP2,GADD45A,
urinary bladder smooth muscle contraction,ATP2B4,P2RX3,P2RX2,HTR2A,TRPV1,PLA2G6,
negative regulation of cellular response to vascular endothelial growth factor stimulus,ATP2B4,ADAMTS12,
regulation of lymphocyte activation,LAX1,LCK,
spinal cord oligodendrocyte cell differentiation,SOX13,SOX6,ASCL1,NKX2-2,OLIG2,
endocardial cushion morphogenesis,MDM4,TGFB2,BMPR1A,ACVRL1,MDM2,NOG,TBX2,SOX9,ACVR1,BMP2,ISL1,TWIST1,TBX20,NOS3,HEY1,ENG,NOTCH1,HEYL,
regulation of astrocyte differentiation,CNTN2,EPHA4,
regulation of oligodendrocyte differentiation,SLC45A3,OPALIN,WDR1,TNFRSF21,
cellular response to vascular endothelial growth factor stimulus,MAPKAPK2,NRP1,RELA,NR4A1,FLT1,SPRY2,PRKD1,AKT1,DLL4,MT1G,MAP2K3,RAMP2,ERN1,SPHK1,PRKD2,ITGB1BP1,KDR,SEMA6A,FLT4,MAPK14,VEGFA,HSPB1,EGR3,ANXA1,GAS1,DAB2IP,NOTCH1,VCAM1,
negative regulation of vascular smooth muscle cell proliferation,IL10,PRKG1,PTEN,PDCD4,GSTP1,CDKN1B,TGFB3,TPM1,MYOCD,CNN1,HMOX1,PPARG,ADIPOQ,MEF2C,CDKN1A,SOD2,GPER1,APLN,
negative regulation of myeloid dendritic cell activation,IL10,TSPAN32,HAVCR2,
endothelial cell apoptotic process,IL10,FGF21,BMPR2,COL4A3,TNF,MAP3K5,DAB2IP,HIPK1,
negative regulation of endothelial cell apoptotic process,IL10,GATA3,GAS6,PDPK1,CDH5,MAPK7,RAMP2,ANGPTL4,ICAM1,PAK4,FGF21,NFE2L2,SCG2,GATA2,TNIP2,KDR,NDNF,FGB,FGA,FGG,TERT,SEMA5A,IL13,IL4,TNFAIP3,KRIT1,SERPINE1,BRAF,ANGPT1,TEK,ABL1,
hematopoietic stem cell proliferation,CD34,ETV6,WNT10B,WNT1,SART3,CTC1,YJEFN3,RUNX1,ARIH2,WNT5A,MECOM,SFRP2,NKAP,WNT2B,YTHDF2,
endothelial cell proliferation,CD34,CALCA,APOA1,SCARB1,HMGB1,MMP14,NOX5,ERN1,BMPR2,XBP1,HMOX1,PROK2,PIK3CB,DLG1,LOXL2,THAP1,TEK,PRKX,
glomerular endothelium development,CD34,FOXC2,
endothelium development,CD34,SLC40A1,KDR,GJA1,GJA4,
mesangial cell-matrix adhesion,CD34,CCL21,
metanephric glomerular mesangial cell differentiation,CD34,
positive regulation of endothelial cell migration,PROX1,AGT,GATA3,NRP1,ETS1,SCARB1,PRKD1,BMP4,THBS1,BCAR1,FOXC2,GRN,ITGB3,BCAS3,PRKCA,CCBE1,CALR,GPI,PRKD2,FUT1,RRAS,EMC10,ZNF580,ITGB1BP1,ROCK2,RHOB,ATOH8,BMPR2,NRP2,AAMP,ANGPT4,RIN2,WNT7A,TDGF1,WNT5A,FOXP1,KDR,ANXA3,PDCD6,FGF1,SPARC,FLT4,EDN1,GPLD1,VEGFA,SASH1,SMOC2,PTK2B,ADGRA2,ANGPT1,GFUS,TEK,ABL1,ZC3H12A,
aorta smooth muscle tissue morphogenesis,PROX1,COL3A1,MYLK,
skeletal muscle thin filament assembly,PROX1,ACTA1,ACTC1,TCAP,TTN,LMOD3,
atrial cardiac muscle tissue morphogenesis,PROX1,MYH6,NOG,BMP10,WNT2,ENG,
regulation of transcription involved in lymphatic endothelial cell fate commitment,PROX1,NR2F2,
endocardium formation,PROX1,OVOL2,SOX18,SOX17,
lymphatic endothelial cell differentiation,PROX1,ACVRL1,BMPR2,SOX18,ACVR2B,
endothelial cell differentiation,PROX1,MESP1,KDM6B,HOXB5,CXCR4,SCUBE1,KDR,NOTCH4,PTN,EDF1,S1PR1,SETSIP,
lens fiber cell morphogenesis,PROX1,ABI2,CRYGB,TBC1D20,ATF4,EPHA2,
acinar cell differentiation,PROX1,
regulation of striated muscle tissue development,CENPF,SMAD3,TGFB1,LOX,MTPN,
negative regulation of cardiac muscle cell proliferation,KCNK2,PTEN,RBP4,TBX5,SAV1,NOG,MEIS1,CXADR,MAPK11,VGLL4,TGFBR2,RIPK1,JARID2,GJA1,CITED2,TP73,
cardiac muscle cell proliferation,TGFB2,TENM4,ARID2,NDRG4,FOXC2,PRKAR1A,BMP10,DIPK2A,SMAD1,NKX2-5,FOXC1,RXRA,NOTCH1,TGFBR3,
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,TGFB2,ACVR1,TGFBR2,TGFBR1,ENG,
endocardial cushion fusion,TGFB2,ACVR1,GATA5,TGFBR2,
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,TGFB2,NOG,
oligodendrocyte differentiation,DUSP10,BNIP3,NKX6-2,SOX6,MYRF,ASCL1,TRPC4,NKX2-1,SLC8A3,CSK,SOX8,ERBB2,CNP,SOX9,GPR17,BOK,OLIG2,OLIG1,SOX10,NKX6-1,TPPP,GLI3,PTPRZ1,CDK5,SHH,NRG1,NTRK2,NOTCH1,NLGN3,TSPAN2,CDKN2C,
negative regulation of oligodendrocyte differentiation,DUSP10,NF1,TMEM98,ID2,DLX1,DLX2,CTNNB1,DRD3,HES1,ID4,DAAM2,NOTCH1,HES5,
negative regulation of lymphocyte migration,MIA3,AKT1,GCSAM,ADTRP,WASL,
positive regulation of cardiac muscle cell apoptotic process,CAPN2,AGT,PTEN,BNIP3,TIGAR,LTK,TP53,CXCR2,CAMK2D,POU4F2,HMGCR,CAMK2A,MAP3K5,
positive regulation of cardiac muscle hypertrophy,PARP1,AGT,TWF1,IGF1,MEF2A,PRKCA,ROCK1,ROCK2,BMP10,PDE9A,PPP3CA,CAMK2D,PDE5A,HAND2,IL6ST,EDN1,MTPN,ADRA1A,PTK2,NR4A3,CDK9,SLC9A1,
common myeloid progenitor cell proliferation,ITPKB,GSTP1,FLT3,CEACAM1,FBXO4,UNCX,NR4A3,
positive regulation of cardiac muscle cell differentiation,WNT3A,EFNB2,GREM1,ARRB2,MYOCD,KAT2A,MEF2C,NRG1,
positive regulation of skeletal muscle tissue development,WNT3A,CDON,CTNNB1,PRKAA1,HMGCR,MEF2C,FLOT1,SHH,
cardiac muscle cell fate commitment,WNT3A,WT1,TBX3,ACVR1,
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,WNT3A,WNT8A,
positive regulation of oligodendrocyte progenitor proliferation,GJC2,LRP2,LYN,
skeletal muscle fiber adaptation,ACTA1,MYOZ1,MYOD1,MYOZ2,
artery smooth muscle contraction,AGT,HTR2A,SCNN1B,BBS2,MKKS,GRIP2,CD38,EDNRA,EDN1,EDN2,
smooth muscle cell proliferation,AGT,CCN3,NAA35,
cell growth involved in cardiac muscle cell development,AGT,AKAP13,MAP2K4,PDLIM5,SORBS2,GATA4,ADRA1A,AGTR2,NPPA,
uterine smooth muscle contraction,AGT,
positive regulation of vascular associated smooth muscle cell migration,AGT,PAK1,LRP1,MDM2,SSH1,FGF9,IQGAP1,IGFBP5,ADAMTS1,PDGFB,TERT,DOCK4,DOCK5,NR4A3,ATP7A,DOCK7,
positive regulation of branching involved in ureteric bud morphogenesis,AGT,PAX2,LGR4,SIX1,SIX4,GREM1,SOX8,HOXB7,NOG,SOX9,TGFB1,PAX8,GDNF,VEGFA,SMO,MAGED1,AGTR2,WNT2B,
lymphatic endothelial cell migration,LGALS8,LGALS12,
cardiac muscle cell development,ACTN2,HNRNPU,LRRC10,ALPK3,ALPK2,SLC8A1,CAV3,SGCB,MTOR,
cardiac muscle hypertrophy,RYR2,CSRP3,TCAP,TTN,HTR2B,TIAM1,HDAC2,HEY2,LEP,
Purkinje myocyte to ventricular cardiac muscle cell signaling,RYR2,CASQ2,
response to muscle stretch,RYR2,ANKRD1,RELA,NFKBIA,FOS,TCAP,GPI,SLC8A1,RAF1,NFKB1,EDN1,MAPK14,DMD,JUN,SLC9A1,NPPA,
regulation of ventricular cardiac muscle cell action potential,RYR2,CTNNA3,CACNA1C,PKP2,JUP,DSC2,DSG2,TRPM4,DLG1,DSP,CAV1,
ventricular cardiac muscle cell action potential,RYR2,KCNQ1,KCNE3,SCN3B,PKP2,NEDD4L,KCNE4,SNTA1,KCNE2,KCNE1,CAV3,GPD1L,SCN5A,ANK2,KCNH2,KCNE5,
regulation of atrial cardiac muscle cell action potential,RYR2,ANK2,
left ventricular cardiac muscle tissue morphogenesis,RYR2,SMAD4,
regulation of vascular smooth muscle contraction,CHRM3,ATP2B1,P2RX1,
positive regulation of vascular smooth muscle contraction,CHRM3,RHOA,
positive regulation of blood vessel endothelial cell migration,AKT3,SIRT1,AMOTL1,ETS1,SP1,ATP5F1B,P2RX4,HMGB1,PRKD1,HIF1A,AKT1,THBS1,PDPK1,ALOX12,MAP2K3,STAT5A,PRKCA,ATP5F1A,PRKD2,ADAM17,NFE2L2,ANGPT4,PLCG1,CD40,PDGFB,GATA2,KDR,FGF2,VEGFC,FGF18,VEGFA,NUS1,HSPB1,NOS3,FGFR1,ANGPT1,TMSB4X,
positive regulation of vascular endothelial cell proliferation,AKT3,IGF2,MDK,SP1,HMGB1,PDPK1,STAT3,SIRT6,ADAM17,ITGA4,PLCG1,GHRL,GHSR,FGF2,FGFR1,APLN,
ureteric bud invasion,KIF26B,FMN1,SALL1,
regulation of lymphocyte migration,GCSAML,GCSAM,STK10,MSN,
negative regulation of lymphocyte proliferation,IL2RA,GAL,SOX11,IL2,LST1,FOXP3,
ureteric bud formation,GATA3,GREM1,NOG,GDNF,
canonical Wnt signaling pathway involved in metanephric kidney development,GATA3,LGR4,
positive regulation of ureteric bud formation,GATA3,SIX1,SIX4,GDNF,
lymphocyte migration,GATA3,SPNS2,TBX21,CCR6,
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,GATA3,
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,GATA3,
smooth muscle tissue development,ITGA8,BMP4,STRA6,NF1,IHH,TIPARP,DLG1,PDGFRB,FOXP2,SMO,SHH,ZFAND5,PTCH1,ENG,
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,ITGA8,MYOCD,NPNT,
lens fiber cell development,VIM,WNT5B,FRS2,CRYGB,BFSP1,WNT7B,WNT7A,BFSP2,TMOD1,
ganglioside biosynthetic process,ST8SIA6,B4GALNT1,ST8SIA2,ST8SIA3,ST3GAL5,ST8SIA4,B3GALT4,ST6GALNAC6,ST6GALNAC4,ST6GALNAC5,ST6GALNAC3,
neuromuscular junction development,CACNB2,ANK3,PPFIBP2,PPFIBP1,LRRK2,CACNB3,P2RX2,COL4A1,UNC13C,NEDD4,DNAJA3,CACNB1,ERBB2,AFG3L2,UNC13A,DCTN1,CACNB4,CHRNA1,ALS2,CACNG2,LAMB2,CACNA2D2,PDZRN3,KALRN,DOK7,UTRN,FNTA,UNC13B,MUSK,TNC,ZC4H2,COL4A5,DVL1,RER1,AGRN,
membrane depolarization during atrial cardiac muscle cell action potential,CACNB2,CACNA1C,SCN5A,
muscle fiber development,NEBL,MYOF,NRAP,MYL2,WFIKKN1,CHRNB1,WFIKKN2,AFG3L2,COMP,DYSF,NEB,CACNA2D2,UCHL1,SGCB,PTCD2,LOX,FLNC,DMD,
cardiac muscle thin filament assembly,NEBL,NRAP,NEB,
megakaryocyte development,PIP4K2A,ABI1,FLI1,PTPN6,ZNF385A,SH2B3,PTPN11,ZFPM1,MED1,MEIS1,EP300,THPO,KIT,MPIG6B,SRF,WASF2,TAL1,
amacrine cell differentiation,PTF1A,NEUROD4,FOXN4,NEUROD1,RORB,
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,APBB1IP,ITGAL,ICAM1,FGL2,
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,JCAD,APLNR,PPP1R16B,HMOX1,GATA2,AGTR1,FGFBP1,APELA,VEGFA,
positive regulation of vascular endothelial growth factor signaling pathway,JCAD,MYO1C,CCBE1,ROBO1,ADAMTS3,SMOC2,
negative regulation of endothelial cell differentiation,ZEB1,ACVRL1,XDH,ID1,NOTCH4,
regulation of smooth muscle cell differentiation,ZEB1,FGFR2,BMP4,MYOCD,SRF,
vascular smooth muscle cell differentiation,EPC1,MYOCD,
vascular endothelial growth factor signaling pathway,NRP1,VEGFB,FLT3,FLT1,PGF,NRP2,KDR,GAB1,VEGFC,FLT4,FOXC1,VEGFA,NUS1,VEGFD,
retinal ganglion cell axon guidance,NRP1,SLIT1,ISL2,PTPRM,SEMA4F,ROBO2,RPL24,ALCAM,EPHB1,EPHB3,SLIT2,BMPR1B,POU4F2,ISL1,EFNA5,POU4F3,EPHA7,NRCAM,EPHB2,
sympathetic ganglion development,NRP1,ASCL1,NRP2,INSM1,CTNNB1,SEMA3F,PHOX2B,SEMA3A,FZD3,
trigeminal ganglion development,NRP1,SIX1,SIX4,NRP2,SEMA3A,
regulation of retinal ganglion cell axon guidance,NRP1,POU4F2,VEGFA,
endothelial tip cell fate specification,NRP1,DLL1,
positive regulation of retinal ganglion cell axon guidance,NRP1,VEGFA,
facioacoustic ganglion development,NRP1,NRP2,SEMA3A,
dorsal root ganglion morphogenesis,NRP1,NRP2,
regulation of satellite cell activation involved in skeletal muscle regeneration,GJD4,
lymphocyte migration into lymphoid organs,RET,CRTAM,FUT7,ARTN,
positive regulation of metanephric glomerulus development,RET,PAX2,AGTR2,
ureteric bud development,RET,FGFR2,BDNF,WT1,CAT,GDF11,BMP4,SIX1,ARG2,SMAD6,SMAD3,SALL1,FOXC2,RARA,NOG,SMAD2,SMAD7,BCL2,CRLF1,TGFB1,OSR1,SDC1,EPCAM,SDC4,BMP7,RARB,ROBO2,DLG1,SLIT2,NPNT,SPRY1,SMAD1,GDNF,SMAD5,FOXC1,SIM1,TCF21,BMPER,FGFR1,SFRP1,EYA1,CER1,
negative regulation of endothelial cell proliferation,ALOX5,ACVRL1,RGCC,CNMD,SYNJ2BP,VASH1,THBS1,NR2F2,NF1,APOH,PTPRM,ATP5F1A,APOE,XDH,ATOH8,STAT1,SCG2,GHRL,AIMP1,SPARC,PRL,TNF,GJA1,KRIT1,CAV2,CAV1,SULF1,TGFBR1,TNMD,ATP5IF1,
positive regulation of leukocyte adhesion to arterial endothelial cell,ALOX5,TNF,
neuromuscular synaptic transmission,CHAT,P2RX3,CHRM1,FCHSD2,STAC3,RIMBP2,P2RX2,CHRNB1,DTNA,CACNA1A,RAB3A,SLC5A7,CHRNA1,MYLK2,ADARB1,ETV5,FCHSD1,EGR3,STXBP1,KIF1B,
negative regulation of vascular associated smooth muscle cell migration,PRKG1,TPM1,MYOCD,NFE2L2,ADIPOQ,MEF2C,
negative regulation of cardiac muscle cell differentiation,DKK1,SOX6,FRS2,FZD7,BMP2,DLL1,
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,DKK1,
positive regulation of membrane depolarization during cardiac muscle cell action potential,ANK3,
positive regulation of cardiac muscle cell proliferation,CDK1,BMPR1A,FGFR2,YAP1,GLI1,TBX5,FGF9,TBX2,GATA6,BMP10,ERBB4,MAPK1,RBPJ,FGF2,CCNB1,MEF2C,MAPK14,PIM1,HEY2,TBX20,WNT2,FGFR1,ZFPM2,NOTCH1,TGFBR3,
muscle organ morphogenesis,ARID5B,SMTNL1,CNTF,MYF5,GSC,TCF15,TBX1,LIF,SERP1,
positive regulation of oligodendrocyte differentiation,ZNF365,MDK,TENM4,PRMT5,IL34,ASPA,CXCR4,NKX2-2,OLIG2,PPARG,DAG1,GSX2,TLR2,HDAC2,PTPRZ1,PTN,RHEB,SHH,HDAC1,TNFRSF1B,TP73,MTOR,
regulation of smooth muscle cell apoptotic process,SIRT1,PDE1A,RBM10,
positive regulation of smooth muscle cell differentiation,SIRT1,PIAS1,MYOCD,OLFM2,TGFB1,SMARCD3,
maintenance of gastrointestinal epithelium,PBLD,RBP4,MUC6,STRAP,SERPINA3,NOD2,TFF3,TFF2,TFF1,TLR9,MUC13,MUC4,CRACD,VSIG1,
positive regulation of myeloid dendritic cell cytokine production,DDX21,TICAM1,DDX1,MAVS,DHX36,DDX58,
intestine smooth muscle contraction,TACR2,HTR2B,PTGER3,HTR1D,
regulation of uterine smooth muscle contraction,TACR2,SETD3,TACR1,
positive regulation of uterine smooth muscle contraction,TACR2,ABAT,TACR1,OXT,OXTR,TACR3,GPER1,
ganglioside GM1 transport to membrane,PSAP,
negative regulation of skeletal muscle tissue regeneration,MYOZ1,
regulation of skeletal muscle adaptation,CAMK2G,CAMK2B,
regulation of relaxation of cardiac muscle,CAMK2G,CAMK2D,PLN,
regulation of smooth muscle cell migration,PLAU,SORL1,ACE,TACR1,PLXNA1,PDGFA,
regulation of smooth muscle cell-matrix adhesion,PLAU,
regulation of establishment of endothelial barrier,VCL,TNFRSF1A,ROCK1,ROCK2,IL1B,TNF,IKBKB,
smooth muscle contraction involved in micturition,KCNMA1,TRPV1,TACR1,
metanephric collecting duct development,DLG5,PAX2,AQP2,BMP4,PKD1,WNT7B,AKR1B1,SHH,CALB1,PTCH1,
photoreceptor cell morphogenesis,CDHR1,CABP4,C8orf37,MFSD2A,
muscle structure development,LDB3,PDLIM1,CAPN3,RNF165,PDLIM5,PDLIM3,PDLIM4,PDLIM7,PDLIM2,
negative regulation of smooth muscle cell migration,BMPR1A,ILK,LRP1,APEX1,SEMA6D,NDRG4,IGFBP5,SLIT2,PPARGC1A,PPARD,IGFBP3,SERPINE1,TRIB1,
endocardial cushion formation,BMPR1A,BMP7,ROBO2,ROBO1,BMP5,TBX20,
regulation of cardiac muscle cell proliferation,BMPR1A,MAPK11,NKX2-5,FGF20,TGFBR1,
negative regulation of vascular endothelial growth factor receptor signaling pathway,MMRN2,HHEX,CNMD,NEDD4,EPN2,HGS,CADM4,EMILIN1,PTPN1,PDCD6,DAB2IP,NIBAN2,TNMD,
regulation of myeloid cell apoptotic process,PTEN,THRA,
cardiac muscle tissue development,PTEN,RBP4,CSRP3,SGCG,ALDH1A2,NPRL3,GJC1,TBX2,NDUFV2,GATA6,BMP7,GATA5,SGCD,NKX2-5,BMP5,PLN,SGCZ,NRG1,ZFPM2,TAZ,MTOR,
vascular smooth muscle contraction,ACTA2,PIK3C2A,COMP,SLC8A1,RAP1GDS1,
glomerular mesangial cell development,ACTA2,FOXC2,GPR4,NOTCH1,
cardiac muscle tissue morphogenesis,ANKRD1,ACTC1,ZFPM1,TCAP,XIRP2,TTN,BMP2,MYLK2,NKX2-5,TBX20,NOTCH1,
regulation of vascular endothelial growth factor receptor signaling pathway,MYOF,FZD4,TMEM204,VEGFC,
lymphocyte proliferation,HELLS,FLT3,IMPDH2,PURA,IMPDH1,HPRT1,
negative regulation of skeletal muscle tissue growth,TLL2,MSTN,
mucosal-associated lymphoid tissue development,NKX2-3,
striated muscle cell differentiation,CHUK,CASP7,IGF2,MYOD1,CDON,KRAS,RB1,AKT1,BNIP2,SPAG9,CDH2,IGFBP5,POPDC2,CASP3,MAPK14,BVES,POPDC3,MTPN,SHH,
metanephric mesenchymal cell differentiation,PAX2,OSR1,STAT1,TCF21,WNT4,
mesenchymal to epithelial transition involved in metanephros morphogenesis,PAX2,BMP4,GREM1,SALL1,SIX2,PAX8,GDNF,
metanephric mesenchyme development,PAX2,WT1,SIX1,SIX4,OSR1,PKD2,BASP1,PDGFRB,
metanephric epithelium development,PAX2,WT1,OSR1,PAX8,WNT7B,
metanephric nephron tubule formation,PAX2,SOX8,SOX9,PAX8,
retinal pigment epithelium development,PAX2,MED1,IHH,TBC1D32,MFSD2A,
regulation of metanephros size,PAX2,AGTR2,
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,PAX2,PAX8,LIF,GDNF,
metanephric distal convoluted tubule development,PAX2,UMOD,PAX8,CALB1,
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,PAX2,PAX8,
regulation of metanephric nephron tubule epithelial cell differentiation,PAX2,YAP1,PAX8,LIF,WWTR1,FAT4,
negative regulation of mesenchymal cell apoptotic process involved in metanephros development,PAX2,PAX8,
negative regulation of apoptotic process involved in metanephric collecting duct development,PAX2,PAX8,
negative regulation of apoptotic process involved in metanephric nephron tubule development,PAX2,PAX8,
positive regulation of metanephric DCT cell differentiation,PAX2,PAX8,
primary ureteric bud growth,LZTS2,
epithelial to mesenchymal transition involved in endocardial cushion formation,FGF8,TMEM100,SMAD4,SNAI1,MSX1,RBPJ,MSX2,HEY2,SNAI2,ENG,NOTCH1,HEYL,
negative regulation of cardiac muscle tissue development,FGF8,FGF3,
photoreceptor cell development,ARL3,RP1L1,RP1,DCX,
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,GSTO1,
negative regulation of vascular smooth muscle cell differentiation,PDCD4,NFATC3,NFATC1,NFATC2,PDGFB,
positive regulation of vascular associated smooth muscle cell apoptotic process,PDCD4,STK4,ATF4,PPARG,E2F3,SOD2,MFN2,
positive regulation of smooth muscle cell apoptotic process,PDCD4,ARRB1,IFNG,MAP2K4,IL12A,IL12B,CDKN2A,RBM10,
voluntary musculoskeletal movement,VTI1A,MAP1A,VPS35,XRCC1,ITPR1,HIPK2,MTOR,
regulation of smooth muscle cell proliferation,TCF7L2,BMP4,TACR1,PDE1A,XRCC5,NPPC,XRCC6,CTNNB1,ELN,PRKDC,NR4A3,
muscle cell cellular homeostasis,BAG3,LARGE2,PFKM,CFL2,HIF1A,CAPN3,ALDOA,GAA,TGFB1,CHRNA1,MSTN,SOD1,LARGE1,CAV3,LOX,SRF,PLG,SGCZ,TRIM32,DMD,LAMP2,MTM1,
negative regulation of striated muscle cell apoptotic process,BAG3,NACA,NOL3,BMP7,HMGCR,
cardiac muscle hypertrophy in response to stress,INPP5F,ATP2A2,MYH6,MYH7,CAMTA2,TCAP,GATA6,HDAC4,KLF15,PPP3CA,MEF2C,HEY2,EZH2,NPPA,
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,FGFR2,FRS2,HOXB13,HOXD13,ESR1,SFRP1,
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,FGFR2,TP63,
neuroendocrine cell differentiation,BCCIP,WNT11,
cardiac muscle cell apoptotic process,BNIP3,APAF1,NOL3,RPS6KA2,GNGT1,GNB1,
positive regulation of thymocyte apoptotic process,ADAM8,TP53,NFKBID,BBC3,ZC3H8,WNT5A,
positive regulation of fibronectin-dependent thymocyte migration,ADAM8,
regulation of muscle cell differentiation,IGF2,SUPT6H,CAMK1,MEGF10,CDK9,
myoblast fusion involved in skeletal muscle regeneration,CD81,CD9,MYMK,PTGFRN,
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,CD81,LGALS9,HLA-DMB,
regulation of atrial cardiac muscle cell membrane repolarization,KCNQ1,KCNA5,SCN5A,CACNA1D,KCNE5,NPPA,
membrane repolarization during ventricular cardiac muscle cell action potential,KCNQ1,KCNE3,KCNJ5,KCNJ8,KCNJ3,KCNE4,KCNE2,KCNE1,KCNH2,KCNE5,KCND3,
atrial cardiac muscle cell action potential,KCNQ1,SCN3B,KCNA5,GJC1,SCN5A,ANK2,NUP155,GJA1,KCNE5,
membrane repolarization during atrial cardiac muscle cell action potential,KCNQ1,KCNJ5,KCNA5,KCNJ3,KCNN2,
regulation of lens fiber cell differentiation,CDKN1C,CDKN1B,
negative regulation of cardiac muscle cell apoptotic process,ILK,MDK,AMBRA1,SIRT4,PDPK1,NUPR1,NOL3,MYOCD,HSPB6,PAX8,NFE2L2,CFLAR,SFRP2,HAND2,NKX2-5,SIRT5,PPP1R10,RGL2,HEY2,GATA4,HSF1,JAK2,
cell migration involved in endocardial cushion formation,DCHS1,SNAI2,ENG,NOTCH1,
protein localization to photoreceptor outer segment,TUB,ROM1,SPATA7,BBS4,PCARE,ZDHHC3,TULP1,
vascular smooth muscle cell development,ADM,RAMP2,COMP,HES1,SGCB,HEY2,ENG,
smooth muscle cell chemotaxis,PARVA,PDGFRB,
positive regulation of skeletal muscle cell differentiation,ARNTL,GPC1,MEF2C,
oligodendrocyte cell fate specification,SOX6,PAX6,OLIG2,
astrocyte differentiation,SOX6,PAX6,STAT3,NKX2-2,S100B,EIF2B5,NOTCH1,HES5,
positive regulation of uterine smooth muscle relaxation,ABCC8,
positive regulation of skeletal muscle tissue regeneration,MYOD1,TGFBR2,PPARD,
detection of muscle stretch,CSRP3,TCAP,TTN,CAV3,
trophoblast giant cell differentiation,E2F8,E2F7,NR2F2,SOX15,SOCS3,SNAI1,LIF,SENP2,PLK4,HAND1,MDFI,PRDM1,PLG,GJB5,
cell differentiation involved in metanephros development,LGR4,
metanephric glomerulus development,LGR4,
metanephric nephron tubule morphogenesis,LGR4,HES1,HES5,
metanephric S-shaped body morphogenesis,WT1,PAX8,PKD2,PDGFRB,
negative regulation of metanephric glomerular mesangial cell proliferation,WT1,
positive regulation of metanephric ureteric bud development,WT1,BASP1,
positive regulation of leukocyte adhesion to vascular endothelial cell,TRAF6,MDK,RELA,ETS1,NFAT5,ICAM1,ITGB2,RHOA,TNF,IL6,FUT7,IRAK1,
positive regulation of smooth muscle cell chemotaxis,MDK,PDGFD,AIF1,LPAR1,
skeletal muscle acetylcholine-gated channel clustering,LRP4,DNAJA3,COLQ,ETV5,FNTA,MUSK,DVL1,RER1,
synaptic growth at neuromuscular junction,LRP4,SHANK2,SHANK1,APP,
positive regulation of skeletal muscle acetylcholine-gated channel clustering,LRP4,MESD,PTN,
regulation of muscle filament sliding,MYBPC3,MYLK2,
lymphoid progenitor cell differentiation,SPI1,BMP4,BATF,BCL2,TREX1,KIT,SHH,
myeloid leukocyte differentiation,SPI1,PSEN1,KIT,
lymphocyte differentiation,SPI1,FLT3,CBFB,RELB,FLT3LG,IKZF1,PRKDC,TOX,LY6D,
positive regulation of neuromuscular synaptic transmission,RAPSN,
negative regulation of photoreceptor cell differentiation,CNTF,SOX8,SOX9,DLX1,DLX2,NOTCH1,
astrocyte activation,CNTF,IFNG,PSEN1,MAPT,C5AR1,FPR2,IL1B,APP,BACE2,ADORA2A,TNF,AGER,TREM2,IFNGR1,EGFR,SMO,C1QA,
positive regulation of astrocyte differentiation,PRPF19,CLCF1,MAG,ID2,BIN1,SERPINE2,BMP2,LIF,HES1,IL6ST,NOTCH1,
camera-type eye photoreceptor cell differentiation,ROM1,TTC8,SDK2,DSCAM,PROM1,
negative regulation of myeloid progenitor cell differentiation,DPF2,
regulation of the force of skeletal muscle contraction,ACTN3,MYH7,
positive regulation of fast-twitch skeletal muscle fiber contraction,ACTN3,ATP2A1,
positive regulation of skeletal muscle tissue growth,ACTN3,NACA,DLL1,MTM1,
regulation of muscle system process,ACTN3,
negative regulation of relaxation of muscle,ACTN3,TIFAB,NEUROG1,
negative regulation of relaxation of smooth muscle,GRK2,
negative regulation of smooth muscle cell chemotaxis,CORO1B,GSTP1,SLIT2,AIF1,
retinal bipolar neuron differentiation,CABP4,IRX5,VSX1,ZHX2,
regulation of endothelial cell chemotaxis to fibroblast growth factor,FGF4,FGF2,FGF1,
establishment of endothelial barrier,PDE2A,RDX,ROBO4,RAPGEF3,RAP1B,ICAM1,MYADM,PPP1R16B,SOX18,RAPGEF2,PDE4D,MARVELD2,F2RL1,EZR,RAPGEF1,MSN,RAP1A,
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,KCNE3,
ganglioside catabolic process,NEU3,HEXA,NEU2,NEU4,HEXB,GM2A,NEU1,
ureteric bud morphogenesis,WNT11,HES1,TACSTD2,
positive regulation of microglial cell activation,CTSC,MMP8,LRRK2,STAP1,TREM2,TTBK1,TAFA3,
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,DEUP1,CEP152,CCDC78,CEP63,PLK4,
multi-ciliated epithelial cell differentiation,DEUP1,TTC8,E2F4,MCIDAS,CCNO,
negative regulation of vascular smooth muscle contraction,ARHGAP42,DOCK4,DOCK5,
intestinal epithelial cell development,YAP1,TIGAR,KLF5,SRC,NKX3-2,IL6ST,SPDEF,PRDM1,C1GALT1,YIPF6,
cardiac muscle tissue regeneration,YAP1,ERBB4,GATA4,
regulation of microglial cell activation,MMP8,ATM,SPHK1,IL6,
regulation of relaxation of muscle,SLN,PLN,SRI,
metanephric proximal convoluted tubule development,ACAT1,
blood vessel endothelial cell migration,APOA1,SCARB1,EMP2,CDH5,ID1,SOX18,MYH9,GPX1,PTK2B,AMOT,
cardiac muscle cell action potential involved in contraction,SCN4B,SCN2B,SCN3B,CACNA1C,PKP2,CACNA1G,KCNJ2,SCN1B,SCN1A,KCNE2,KCNE1,SCN5A,CACNA1D,FGF12,CACNA2D1,ATP1A1,
regulation of atrial cardiac muscle cell membrane depolarization,SCN2B,SCN3B,CACNA1G,SCN1B,SCN5A,SCN10A,
regulation of lymphocyte apoptotic process,CD3G,
myeloid progenitor cell differentiation,SLC37A4,JAM3,FLT3,MLF1,KIT,BRAF,
regulation of ventricular cardiac muscle cell membrane depolarization,SCN3B,SMAD7,CAV3,GPD1L,SCN5A,
skeletal muscle satellite cell differentiation,CDON,KLF5,MYLK2,MEGF10,
ventricular cardiac muscle cell membrane repolarization,KCNJ5,KCNJ3,KCND3,
hematopoietic stem cell migration to bone marrow,JAM3,GAS6,JAM2,GPLD1,
lymphocyte migration into lymph node,WNK1,CCR7,
negative regulation of hepatic stellate cell migration,ADIPOR2,
ganglion development,TULP3,
neuromuscular process,KCNA1,PEX5,HOXC10,SPART,MYCBP2,STRA6,AARS1,RAC3,CACNA1A,COMP,OPA3,DCTN1,CHRNA1,HOXD10,CHRND,UBA5,FGF12,UCHL1,GLRB,HEXB,GLRA1,POMK,AGTPBP1,GRIN1,MECP2,ZMPSTE24,KCNAB2,
hematopoietic or lymphoid organ development,LTBR,ASXL1,
regulation of skeletal muscle contraction,C12orf57,SLC8A3,CAV3,DMD,
negative regulation of blood vessel endothelial cell differentiation,FOXJ2,
positive regulation of myeloid dendritic cell activation,CLEC4D,CD2,
positive regulation of lymphocyte activation,CLEC7A,SASH3,
negative regulation of skeletal muscle tissue development,YBX3,USP19,TWIST1,
negative regulation of smooth muscle cell apoptotic process,LRP6,IGF1,ARRB2,APOH,DIPK2A,EDN1,
negative regulation of cardiac muscle tissue regeneration,CDKN1B,CDKN1A,
endothelial cell activation,APOLD1,P2RX4,PRMT5,SMAD4,TCF4,FOXP1,CXCL10,HOXA9,BMPER,PPIA,TGFBR1,
regulation of endothelial cell differentiation,APOLD1,CEACAM1,
negative regulation of megakaryocyte differentiation,H4-16,CIB1,PRMT1,GABPA,PF4,H4C3,H4C8,H4C11,
negative regulation of retinal ganglion cell axon guidance,PTPRO,SLIT2,
positive regulation of gastro-intestinal system smooth muscle contraction,SPX,GHRL,PTAFR,
forebrain astrocyte development,KRAS,NF1,
negative regulation of cardiac muscle cell myoblast differentiation,PRICKLE1,
myoblast differentiation involved in skeletal muscle regeneration,WNT10B,
regulation of skeletal muscle tissue development,WNT10B,MEGF10,
astrocyte-dopaminergic neuron signaling,WNT1,CTNNB1,FZD1,
hematopoietic stem cell differentiation,LMBR1L,SP7,BATF,TP53,MEOX1,HOXB4,ACE,ERCC2,XRCC5,SRF,UFL1,CDK6,SFRP1,MLLT3,TAL1,
negative regulation of endothelial cell migration,ACVRL1,DCN,SYNJ2BP,VASH1,THBS1,DLL4,DNAJA4,NR2F2,SERPINF1,APOH,PTPRM,APOE,BMP10,SP100,ADAMTS9,SLIT2,KRIT1,STC1,ADGRB1,DAB2IP,SVBP,
endothelial tube morphogenesis,ACVRL1,PRKD2,RHOB,CXCR4,CTNNB1,CSNK2B,CCM2,
positive regulation of endothelial cell differentiation,ACVRL1,BTG1,BMP4,TMEM100,VEZF1,ETV2,ATOH8,CTNNB1,BMP6,NOTCH1,
regulation of endothelial cell proliferation,ACVRL1,ALDH1A2,FUT2,FUT1,LEP,
blood vessel endothelial cell proliferation involved in sprouting angiogenesis,ACVRL1,BMP4,ITGB1BP1,SEMA5A,BMPER,NRARP,EPHA2,
regulation of myeloid cell differentiation,RARG,RNF41,LGALS3,CREBBP,PRKCB,CBFB,RUNX1,CSF2,PURB,CSF3R,TAL1,
positive regulation of lymphocyte differentiation,NCKAP1L,STAT5B,INPP5D,XRCC6,PRKDC,
regulation of vascular endothelial growth factor signaling pathway,CD63,TCF4,DLL1,TSPAN12,PTP4A3,
endocardial cushion development,ERBB3,TBX5,BMP4,FOXF1,TMEM100,BMPR2,CRELD1,RBM24,CITED2,GATA4,NOTCH1,
positive regulation of cardiac muscle tissue development,ERBB3,CREB1,
regulation of lymphocyte differentiation,RNF41,IKZF3,NDFIP1,
regulation of skeletal muscle fiber development,NACA,FBXO22,HDAC4,HDAC9,
astrocyte activation involved in immune response,LRP1,PSEN1,GRN,APP,
microglial cell activation,IFNG,ITGAM,CX3CL1,TRPV1,MAPT,AZU1,C5AR1,FPR2,APP,IFNGR2,ITGB2,TLR6,SNCA,TLR2,TLR3,IL13,IL4,TNF,AIF1,AGER,TREM2,IFNGR1,NAMPT,CLU,JAK2,TLR7,TLR8,JUN,C1QA,
muscle tissue morphogenesis,MYF6,MYF5,ADARB1,TBX1,SHOX2,PAX7,
positive regulation of myeloid leukocyte differentiation,KITLG,CD101,
positive regulation of hematopoietic stem cell proliferation,KITLG,N4BP2L2,ATXN1L,KAT7,THPO,PDCD2,
negative regulation of vascular endothelial growth factor signaling pathway,DCN,SPRY2,CADM4,XDH,IL12A,HRG,SEMA6A,IL12B,ADGRA2,DAB2IP,
positive regulation of cell growth involved in cardiac muscle cell development,IGF1,PARP2,AKAP6,PIN1,HAMP,EDN1,DDX39B,MTOR,
negative regulation of vascular associated smooth muscle cell apoptotic process,IGF1,DNMT1,
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,IGF1,FZD7,WNT7A,EZH2,
muscle hypertrophy,IGF1,
spinal cord oligodendrocyte cell fate specification,ASCL1,NKX2-2,OLIG2,
oligodendrocyte cell fate commitment,ASCL1,
musculoskeletal movement_ spinal reflex action,ASCL1,CACNA1A,DRD3,
lung neuroendocrine cell differentiation,ASCL1,
stomach neuroendocrine cell differentiation,ASCL1,
adrenal chromaffin cell differentiation,ASCL1,INSM1,
blood vessel endothelial cell delamination,TRPV4,
regulation of cardiac muscle cell membrane potential,ATP2A2,SLC8B1,FXYD1,EHD3,PLN,TRDN,SLC9A1,
regulation of cardiac muscle cell action potential involved in regulation of contraction,ATP2A2,HCN4,RANGRF,CAV3,CAMK2D,AKAP9,CAV1,FGF13,
muscle cell fate specification,MYL2,
intestinal epithelial cell migration,PTPN11,
regulation of lymphocyte chemotaxis,SLC8B1,
ventricular cardiac muscle tissue development,TBX5,PPP1R13L,ADAMTS9,ZMPSTE24,
smooth muscle cell differentiation,TBX3,NFATC4,BMP4,TMEM204,MRTFB,FOXF1,MYOCD,TBX2,GATA6,ACVR1,MRTFA,CTNNB1,FGF10,MEF2C,HEY2,WNT4,
positive regulation of megakaryocyte differentiation,TESC,GATA2,THPO,HMGB2,FAXDC2,SCIN,MTURN,ZNF16,PITHD1,
positive regulation of lymphocyte apoptotic process,P2RX7,
positive regulation of microglial cell migration,P2RX4,CX3CL1,CX3CR1,P2RY12,TREM2,CSF1,
positive regulation of endothelial cell chemotaxis,P2RX4,PRKD1,LGMN,PRKD2,FGF2,SEMA5A,SMOC2,HSPB1,MET,TMSB4X,
microglial cell migration,P2RX4,P2RY12,
negative regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,FGF9,DNMT1,
involuntary skeletal muscle contraction,ATP8A2,
neuromuscular process controlling posture,ATP8A2,GCH1,PRRT2,CNTNAP1,GAA,SCN1A,PNKD,TCF15,ADARB1,GLRA1,CLN8,SLURP1,MECP2,
intestinal epithelial cell differentiation,CDX2,SAV1,PYY,GATA6,CBFA2T2,GATA5,PTK6,NPY,GATA4,
negative regulation of vascular endothelial cell proliferation,FLT1,CCL2,COL4A3,PPARG,MEF2C,
vascular endothelial growth factor receptor-1 signaling pathway,FLT1,
myeloid dendritic cell activation,HMGB1,PYCARD,STARD7,
positive regulation of myeloid cell differentiation,HMGB1,FES,CSF3,HOXA5,
negative regulation of hematopoietic stem cell differentiation,N4BP2L2,NFE2L2,HSPA9,
endothelial tube lumen extension,STARD13,RHOA,
positive regulation of striated muscle cell differentiation,NEK5,MESP1,SHH,NRG1,TRIM32,MORF4L2,
endothelial cell morphogenesis,CNMD,ID1,COL18A1,HEG1,ARHGEF26,NOTCH4,PLOD3,MET,STC1,COL22A1,COL15A1,TNMD,CLIC4,
satellite cell activation involved in skeletal muscle regeneration,KLF5,
enteric smooth muscle cell differentiation,EDNRB,
endothelin receptor signaling pathway,EDNRB,BCAR1,CRKL,EDNRA,EDN1,PTK2B,BCAR3,
response to endothelin,EDNRB,
vein smooth muscle contraction,EDNRB,EDN3,EDN1,EDN2,
negative regulation of lens fiber cell differentiation,SPRY2,SPRED1,SPRED3,SPRED2,SPRY1,FOXE3,
regulation of astrocyte chemotaxis,GPR183,
negative regulation of oligodendrocyte apoptotic process,GAS6,
regulation of vascular endothelial growth factor production,NDRG2,CCR2,IL6,
endothelial to hematopoietic transition,METTL3,YTHDF2,
astrocyte cell migration,MMP14,CCL2,APCDD1,HEXB,SCRIB,
cardiac muscle fiber development,MYH6,MYH11,TCAP,TTN,CXADR,MYO18B,SGCD,VEGFA,ZMPSTE24,
visceral muscle development,MYH6,
regulation of slow-twitch skeletal muscle fiber contraction,MYH7,
muscle cell development,NFATC4,MEGF10,SGCZ,KDM1A,
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,PRKD1,PRKD2,KDR,VEGFA,HSPB1,
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,FOXA1,RXRA,NOTCH1,WDR77,
prostate gland stromal morphogenesis,FOXA1,CRIP1,ID4,
vascular endothelial growth factor receptor-2 signaling pathway,CLEC14A,KDR,PDCD6,VEGFA,DAB2IP,
vascular endothelial growth factor receptor-3 signaling pathway,CLEC14A,
myeloid cell apoptotic process,ARF6,
negative regulation of branching involved in ureteric bud morphogenesis,BMP4,TACSTD2,
negative regulation of striated muscle tissue development,BMP4,LUC7L,SOX15,SIRT2,LEF1,TWIST1,
positive regulation of cardiac muscle fiber development,BMP4,
pulmonary artery endothelial tube morphogenesis,BMP4,
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BMP4,
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BMP4,
negative regulation of glomerular mesangial cell proliferation,BMP4,BMP7,
mesenchymal cell proliferation involved in ureteric bud development,BMP4,BMP2,GPC3,
ureter smooth muscle cell differentiation,BMP4,SIX1,SOX9,
negative regulation of metanephric S-shaped body morphogenesis,BMP4,
negative regulation of metanephric comma-shaped body morphogenesis,BMP4,
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,LGALS3,HAVCR2,
regulation of synaptic growth at neuromuscular junction,SIX1,SIX4,COLQ,MUSK,AGRN,
regulation of skeletal muscle cell proliferation,SIX1,
regulation of branch elongation involved in ureteric bud branching,SIX1,SIX4,
regulation of skeletal muscle cell differentiation,SIX1,RBFOX1,DDX5,KLHL41,NR1D2,UQCC2,
negative regulation of satellite cell differentiation,SIX4,MSTN,EPHB1,AKIRIN1,
skeletal muscle fiber differentiation,SIX4,KLHL40,
intestinal epithelial cell maturation,HIF1A,TYMS,CDKN1A,HOXA5,
regulation of thymocyte apoptotic process,HIF1A,TP53,
establishment of synaptic specificity at neuromuscular junction,GPHN,F2R,
protein localization to photoreceptor connecting cilium,SPATA7,
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,CHGA,
positive regulation of relaxation of cardiac muscle,CHGA,HRC,
hematopoietic stem cell migration,BCL11B,KIT,GPLD1,
lymphoid lineage cell migration into thymus,BCL11B,FOXN1,
negative regulation of eye photoreceptor cell development,DIO3,THRB,
positive regulation of cardiac muscle myoblast proliferation,MEIS2,GATA6,ATF2,
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,THBS1,DLL4,NGFR,IL12A,PDCD10,IL12B,
negative regulation of endothelial cell chemotaxis,THBS1,HRG,NOTCH1,
negative regulation of lymphocyte activation,TYRO3,AXL,MERTK,
positive regulation of satellite cell activation involved in skeletal muscle regeneration,CAPN3,SOX15,
muscle atrophy,GATM,
negative regulation of smooth muscle cell differentiation,RBPMS2,RCAN1,MED28,ANKRD17,EREG,PRDM6,FOXO4,MECP2,
ganglioside metabolic process,CLN6,GM2A,ITGB8,
cardiac vascular smooth muscle cell differentiation,MESP1,GATA6,SRF,
fast-twitch skeletal muscle fiber contraction,SYNM,
astrocyte fate commitment,SOX8,SOX9,GCM1,TAL1,
metanephric ascending thin limb development,PKD1,UMOD,POU3F3,PKD2,
metanephric proximal tubule development,PKD1,
metanephric distal tubule morphogenesis,PKD1,
positive regulation of striated muscle tissue development,MRTFB,
skeletal muscle myosin thick filament assembly,MYH11,TCAP,TTN,
metanephric thick ascending limb development,UMOD,POU3F3,
relaxation of skeletal muscle,ATP2A1,KCNJ2,
positive regulation of cardiac muscle cell contraction,ATP2A1,
muscle system process,TRIM72,
positive regulation of microglial cell mediated cytotoxicity,ITGAM,TYROBP,STAP1,
positive regulation of endothelial tube morphogenesis,ITGAX,ALOX12,
eye photoreceptor cell differentiation,NKD1,STAT3,AGTPBP1,
somatic muscle development,NKD1,NEB,
microglial cell proliferation,CX3CL1,IL34,CSF1R,CLU,IL33,CSF1,
negative regulation of muscle atrophy,NOL3,MTOR,
response to injury involved in regulation of muscle adaptation,NOL3,
negative regulation of vascular endothelial growth factor production,NUTF2,SARS1,
megakaryocyte differentiation,ZFPM1,IL11,SP3,UBA5,MPIG6B,CDKN2B,GATA1,TAL1,
smooth muscle hypertrophy,CYBA,
cellular response to endothelin,CRK,MYC,
positive regulation of cell migration by vascular endothelial growth factor signaling pathway,MYO1C,GAB1,
negative regulation of muscle cell apoptotic process,ALOX12,ADCYAP1,HMOX1,PTK2B,ZC3H12A,
oligodendrocyte apoptotic process,TP53,TNFRSF21,
regulation of membrane depolarization during cardiac muscle cell action potential,RANGRF,CAV3,SLMAP,
positive regulation of cardiac vascular smooth muscle cell differentiation,MYOCD,GPER1,
ventricular cardiac muscle cell differentiation,MYOCD,RARA,RARB,MEF2C,RXRA,
negative regulation of skeletal muscle cell differentiation,MYOCD,S100B,
smooth muscle cell-matrix adhesion,VTN,DDR1,
myeloid cell development,EVI2B,PABPC4,
negative regulation of astrocyte activation,NR1D1,LDLR,
myeloid dendritic cell chemotaxis,CCR7,ARHGEF5,CCL19,
endothelial cell-cell adhesion,JUP,CYP1B1,THBS4,CCN3,
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,STAT3,JAK2,
microglial cell activation involved in immune response,GRN,TYROBP,IL33,
SA node cell to atrial cardiac muscle cell communication by electrical coupling,GJC1,
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,WNT9B,
metanephric tubule development,WNT9B,SOX9,
metanephric tubule formation,WNT9B,WNT4,
SA node cell to atrial cardiac muscle cell signaling,CACNA1G,
negative regulation of myeloid leukocyte differentiation,NME1,NME2,LYN,
arterial endothelial cell differentiation,TMEM100,HEY2,HEY1,NOTCH1,
endothelial cell development,VEZF1,GPX1,HEG1,CCM2,
muscle cell fate determination,TBX2,MEF2C,
regulation of hematopoietic stem cell proliferation,ACE,EIF2AK2,PIM1,
regulation of skeletal muscle contraction by action potential,SCN4A,
negative regulation of myeloid cell apoptotic process,APOH,BCL2,MIF,MAEA,EPO,CLEC5A,
regulation of skeletal muscle contraction via regulation of action potential,KCNJ2,
cardiac muscle cell action potential,KCNJ2,SLC4A3,DMD,
lung smooth muscle development,SOX9,SRF,
metanephric part of ureteric bud development,FOXJ1,PKD2,CALB1,
negative regulation of hepatic stellate cell activation,CYGB,GCLC,
regulation of oligodendrocyte progenitor proliferation,ADCYAP1,CDH2,EMX1,AFDN,PTPRZ1,
extraocular skeletal muscle development,MYOM1,MYH15,FOXL2,MYOM2,
cardiac muscle cell-cardiac muscle cell adhesion,DSC2,
ganglioside biosynthetic process via lactosylceramide,B4GALT6,B4GALT5,
endocardial cell differentiation,SMAD4,SOX18,NRG1,SOX17,NOTCH1,
metanephric mesenchyme morphogenesis,SMAD4,OSR1,BMP7,
positive regulation of lymphocyte migration,MADCAM1,JAM2,
negative regulation of muscle cell differentiation,PTBP1,ID2,TCF23,
post-embryonic cardiac muscle cell growth involved in heart morphogenesis,SIRT6,
regulation of vascular smooth muscle cell dedifferentiation,OLFM2,
musculoskeletal movement,COMP,VPS54,CHRNA1,CHRND,GIGYF2,CLN8,
myeloid leukocyte activation,TYROBP,
negative regulation of oligodendrocyte progenitor proliferation,SIRT2,
positive regulation of microglia differentiation,TGFB1,
positive regulation of endothelial cell-matrix adhesion via fibronectin,CEACAM6,FUT1,RRAS,RIN2,GFUS,
negative regulation of skeletal muscle satellite cell proliferation,SIX5,MSTN,EPHB1,AKIRIN1,
muscle cell apoptotic process,DMPK,
regulation of skeletal muscle contraction by calcium ion signaling,DMPK,
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,DMPK,
thymocyte apoptotic process,BAX,BCL2L11,BAK1,GLI3,DFFA,
ganglion mother cell fate determination,NTF4,POU6F2,
positive regulation of atrial cardiac muscle cell action potential,TRPM4,
positive regulation of regulation of vascular smooth muscle cell membrane depolarization,TRPM4,
regulation of myeloid dendritic cell activation,FLT3LG,
negative regulation of muscle contraction,TNNT1,
slow-twitch skeletal muscle fiber contraction,TNNT1,MB,
metanephric smooth muscle tissue development,OSR1,PKD2,
mesangial cell development,OSR1,
metanephric nephron tubule development,OSR1,
metanephric glomerulus vasculature development,OSR1,
metanephric interstitial fibroblast development,OSR1,
pattern specification involved in metanephros development,OSR1,FOXD1,
metanephric cap mesenchymal cell proliferation involved in metanephros development,OSR1,
striated muscle cell development,SDC1,
relaxation of smooth muscle,SLC8A1,
lens fiber cell apoptotic process,SIX3,E2F1,TGFBR2,E2F2,
regulation of branching involved in ureteric bud morphogenesis,SIX2,
vascular endothelial cell response to fluid shear stress,SOCS5,
regulation of cardiac muscle hypertrophy in response to stress,BMP10,
positive regulation of tongue muscle cell differentiation,CYP26B1,TBX1,
positive regulation of neuromuscular junction development,DCTN1,
positive regulation of lymphocyte proliferation,TACR1,ZNF335,MYD88,IL12A,FGF10,IL12B,TAC1,TLR4,MPL,
positive regulation of acinar cell proliferation,REG1A,
metanephric macula densa development,POU3F3,
metanephric loop of Henle development,POU3F3,WNT7B,
metanephric DCT cell differentiation,POU3F3,
atrial cardiac muscle cell development,FHL2,NKX2-5,NKX2-6,
smooth muscle adaptation,IL1B,
metanephric comma-shaped body morphogenesis,PAX8,PDGFRB,
negative regulation of ventricular cardiac muscle cell action potential,BIN1,
positive regulation of lens fiber cell differentiation,ZEB2,FGF2,
endocardial cushion cell fate commitment,ACVR1,
positive regulation of amacrine cell differentiation,DLX1,DLX2,
skeletal muscle tissue growth,CHRNA1,CHRND,DLL1,
regulation of intestinal epithelial structure maintenance,NEUROD1,
negative regulation of muscle hypertrophy,MSTN,
myoblast migration involved in skeletal muscle regeneration,MSTN,BIN3,ANXA1,AKIRIN1,
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,STAT1,CTNNB1,CITED1,
metanephric mesenchymal cell proliferation involved in metanephros development,STAT1,BMP7,SHH,
negative regulation of metanephric nephron tubule epithelial cell differentiation,STAT1,
negative regulation of muscle tissue development,IGFBP5,
negative regulation of skeletal muscle hypertrophy,IGFBP5,
metanephric tubule morphogenesis,CXCR2,
camera-type eye photoreceptor cell fate commitment,IHH,
thymocyte migration,CCL20,CCR6,
regulation of striated muscle cell differentiation,HDAC4,HDAC9,
cardiac muscle tissue growth,CCM2L,HEG1,
immune response in nasopharyngeal-associated lymphoid tissue,BPIFA1,TTLL1,
regulation of cardiac muscle tissue development,JPH2,
endocardium development,STK4,RBPJ,STK3,NOTCH1,
striated muscle tissue development,EYA2,SHH,EYA1,PGM5,
esophagus smooth muscle contraction,SULF2,SULF1,
regulation of systemic arterial blood pressure by endothelin,EDN3,RHOA,EDN1,NOS3,EDN2,ECE1,
positive regulation of cardiac endothelial to mesenchymal transition,GATA5,
lymphocyte aggregation,JAM2,RAC2,STK10,
microglia development,APP,NRROS,TLR2,TSPAN2,
regulation of thymocyte migration,AIRE,
regulation of skeletal muscle acetylcholine-gated channel clustering,CRKL,FZD9,
positive regulation of myeloid leukocyte cytokine production involved in immune response,MIF,
negative regulation of lymphocyte differentiation,FBXO7,
skeletal muscle organ development,LARGE1,CNTFR,
smooth muscle hyperplasia,HMOX1,NOS3,
positive regulation of vascular smooth muscle cell dedifferentiation,PDGFB,
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,PDGFB,PDGFRB,PDGFA,
metanephric glomerular mesangial cell development,PDGFB,
positive regulation of metanephric mesenchymal cell migration,PDGFB,
metanephros morphogenesis,WNT7B,CTNNB1,FRAS1,FGF10,
regulation of cardiac muscle hypertrophy,LMCD1,
negative regulation of membrane depolarization during cardiac muscle cell action potential,CAV3,
positive regulation of small intestine smooth muscle contraction,GHRL,GHSR,KIT,
negative regulation of pancreatic stellate cell proliferation,PPARG,
skeletal muscle satellite cell activation,WNT7A,EPHB1,MEGF10,
inferior endocardial cushion morphogenesis,TGFBR2,
regulation of microglial cell migration,CX3CR1,P2RY12,
cranial ganglion development,CTNNB1,
positive regulation of astrocyte chemotaxis,CCR2,
leukocyte adhesion to vascular endothelial cell,CCR2,
atrial cardiac muscle tissue development,TREX1,
metanephric glomerular basement membrane development,LAMB2,
skeletal muscle satellite cell migration,RHOA,RHOC,
muscle attachment,DAG1,
negative regulation of muscle organ development,SFMBT1,
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,WNT5A,
endothelial cell-matrix adhesion,ADAMTS9,
regulation of endothelial tube morphogenesis,FOXP1,CXCL10,ADAMTS12,FGF1,
positive regulation of lymphotoxin A biosynthetic process,CD86,
tonic smooth muscle contraction,MYLK,
relaxation of muscle,P2RY1,
positive regulation of myeloid cell apoptotic process,ADIPOQ,
positive regulation of metanephric glomerular visceral epithelial cell development,ADIPOQ,
negative regulation of metanephric mesenchymal cell migration,ADIPOQ,
negative regulation of stomach neuroendocrine cell differentiation,HES1,
negative regulation of smooth muscle cell-matrix adhesion,APOD,SERPINE1,
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,DLG1,
negative regulation of uterine smooth muscle contraction,ADRA2C,
negative regulation of striated muscle cell differentiation,MSX1,EZH2,
positive regulation of muscle tissue development,PPARGC1A,
endocardium morphogenesis,RBPJ,NOTCH1,
blood vessel endothelial cell fate specification,RBPJ,
arterial endothelial cell fate commitment,RBPJ,
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,RBPJ,
metanephric glomerular capillary formation,PDGFRA,PDGFRB,TCF21,
positive regulation of vascular smooth muscle cell differentiation,KIT,ENG,
positive regulation of pyloric antrum smooth muscle contraction,KIT,
positive regulation of colon smooth muscle contraction,KIT,
positive regulation of stomach fundus smooth muscle contraction,NMU,
cardiac muscle cell myoblast differentiation,REST,ISL1,NRG1,
negative regulation of microglial cell migration,STAP1,
negative regulation of endothelial cell chemotaxis to fibroblast growth factor,CXCL13,
lymphocyte chemotaxis across high endothelial venule,CXCL13,
endothelial cell chemotaxis to fibroblast growth factor,CXCL13,
metanephric cortex development,PKD2,
metanephric cortical collecting duct development,PKD2,
metanephric distal tubule development,PKD2,
positive regulation of cardiac muscle hypertrophy in response to stress,PPP3CA,TRPC3,
leukocyte adhesion to arterial endothelial cell,SLC39A8,
atrial cardiac muscle cell to AV node cell communication,ANK2,
SA node cell to atrial cardiac muscle cell communication,ANK2,
cardiac muscle cell contraction,CAMK2D,SGCD,SLC9A1,
negative regulation of cardiac muscle contraction,PDE5A,SRI,PIK3CG,ZC3H12A,
positive regulation of endothelial cell chemotaxis to fibroblast growth factor,FGF2,FGF18,FGFR1,FGF16,
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,FGF2,
growth factor dependent regulation of skeletal muscle satellite cell proliferation,FGF2,
endothelial cell chemotaxis to vascular endothelial growth factor,GAB1,
negative regulation of amacrine cell differentiation,POU4F2,
GABAergic neuron differentiation in basal ganglia,HELT,
proximal/distal pattern formation involved in metanephric nephron development,IRX2,IRX1,
postganglionic parasympathetic fiber development,GDNF,PLXNA4,
negative regulation of relaxation of cardiac muscle,PDE4D,PDE4B,
regulation of skeletal muscle fiber differentiation,NLN,
dichotomous subdivision of terminal units involved in ureteric bud branching,FOXD1,
metanephric nephron development,FOXD1,TFAP2B,WNT4,
metanephric capsule development,FOXD1,
metanephric capsule specification,FOXD1,
skeletal muscle satellite cell proliferation,MEGF10,
muscle cell proliferation,MEGF10,
positive regulation of intestinal epithelial structure maintenance,SLC22A5,
positive regulation of lung goblet cell differentiation,IL13,
positive regulation of pancreatic stellate cell proliferation,IL13,
branchiomeric skeletal muscle development,PITX1,TCF21,MSC,
regulation of muscle organ development,TIFAB,NEUROG1,
glomerular mesangial cell proliferation,EGR1,
positive regulation of glomerular metanephric mesangial cell proliferation,EGR1,
regulation of myeloid leukocyte differentiation,NDFIP1,
branch elongation involved in ureteric bud branching,FGF1,
metanephric mesenchymal cell migration,PDGFRB,
metanephric glomerular mesangium development,PDGFRB,
metanephric glomerular mesangial cell proliferation involved in metanephros development,PDGFRB,
metanephric glomerulus morphogenesis,PDGFRB,
positive regulation of hepatic stellate cell activation,PDGFRB,MYB,LEP,RPS6KA1,
right ventricular cardiac muscle tissue morphogenesis,NKX2-5,ZFPM2,
positive regulation of hematopoietic stem cell differentiation,FOXC1,
positive regulation of skeletal muscle fiber differentiation,RBM24,
regulation of endothelial cell apoptotic process,TNF,TEK,
positive regulation of muscle hyperplasia,AIF1,
positive regulation of endothelin secretion,AGER,
lung goblet cell differentiation,SPDEF,AGR2,HOXA5,
positive regulation of astrocyte activation,TTBK1,
cardiac vascular smooth muscle cell development,VEGFA,HEY2,NOTCH1,
negative regulation of establishment of endothelial barrier,VEGFA,S1PR3,
lymphotoxin A biosynthetic process,IL17F,BCL10,
negative regulation of cardiac vascular smooth muscle cell differentiation,HEY2,
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,HEY2,HEY1,MECP2,
positive regulation of hepatic stellate cell proliferation,MYB,
hepatic stellate cell activation,AKAP12,GCLM,
positive regulation of hepatic stellate cell migration,AKAP12,
positive regulation of oligodendrocyte apoptotic process,AKAP12,
positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching,SOD2,
DN3 thymocyte differentiation,CCR6,
regulation of skeletal muscle tissue growth,DLL1,
Notch signaling pathway involved in arterial endothelial cell fate commitment,DLL1,
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,TWIST1,
regulation of astrocyte activation,IL6,
lateral ganglionic eminence cell proliferation,GLI3,
blood vessel endothelial cell differentiation,CCM2,
negative regulation of skeletal muscle acetylcholine-gated channel clustering,FZD9,
establishment of endothelial blood-brain barrier,CLDN3,
cardiac endothelial to mesenchymal transition,SEMA3C,
mesenchymal to epithelial transition involved in metanephric renal vesicle formation,SMO,
rod bipolar cell differentiation,PTN,
negative regulation of neuromuscular junction development,PTN,
negative regulation of muscle hyperplasia,NOS3,KLF4,
positive regulation of skeletal muscle cell proliferation,SHH,
negative regulation of ureter smooth muscle cell differentiation,SHH,
positive regulation of ureter smooth muscle cell differentiation,SHH,
negative regulation of kidney smooth muscle cell differentiation,SHH,
positive regulation of kidney smooth muscle cell differentiation,SHH,
endothelial cell activation involved in immune response,TCIM,
stromal-epithelial cell signaling involved in prostate gland development,SFRP1,
metanephric connecting tubule development,CALB1,
endocardial cushion to mesenchymal transition,HAS2,
positive regulation of metanephric cap mesenchymal cell proliferation,MYC,
positive regulation of myeloid dendritic cell chemotaxis,CCL21,
cell proliferation involved in metanephros development,PTCH1,GPC3,
negative regulation of leukocyte adhesion to arterial endothelial cell,KLF4,
positive regulation of skeletal muscle hypertrophy,MYMK,MTOR,
venous endothelial cell differentiation,NOTCH1,
regulation of leukocyte adhesion to vascular endothelial cell,FUT7,
regulation of membrane repolarization during atrial cardiac muscle cell action potential,FLNA,
regulation of membrane repolarization during cardiac muscle cell action potential,FLNA,
positive regulation of striated muscle contraction,ATP1A1,
cardiac muscle tissue growth involved in heart morphogenesis,S1PR1,
positive regulation of aortic smooth muscle cell differentiation,CTH,
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,PLPP3,
negative regulation of lymphocyte chemotaxis,PADI2,
skeletal muscle satellite cell commitment,PAX7,
endothelin maturation,ECE1,
metanephric nephron morphogenesis,WNT4,
lymphatic endothelial cell fate commitment,PDPN,
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,RNF207,
positive regulation of muscle contraction,ENO1,
positive regulation of synaptic growth at neuromuscular junction,AGRN,
